Cite
CD20/TNFR1 dual-targeting antibody enhances lysosome rupture-mediated cell death in B cell lymphoma.
MLA
Kim, Jeong Ryeol, et al. “CD20/TNFR1 Dual-Targeting Antibody Enhances Lysosome Rupture-Mediated Cell Death in B Cell Lymphoma.” Cancer Immunology, Immunotherapy, vol. 72, no. 6, June 2023, pp. 1567–80. EBSCOhost, https://doi.org/10.1007/s00262-022-03344-9.
APA
Kim, J. R., Lee, D., Kim, Y., & Kim, J. Y. (2023). CD20/TNFR1 dual-targeting antibody enhances lysosome rupture-mediated cell death in B cell lymphoma. Cancer Immunology, Immunotherapy, 72(6), 1567–1580. https://doi.org/10.1007/s00262-022-03344-9
Chicago
Kim, Jeong Ryeol, Donghyuk Lee, Yerim Kim, and Joo Young Kim. 2023. “CD20/TNFR1 Dual-Targeting Antibody Enhances Lysosome Rupture-Mediated Cell Death in B Cell Lymphoma.” Cancer Immunology, Immunotherapy 72 (6): 1567–80. doi:10.1007/s00262-022-03344-9.